NDC 60687-305

Aspirin and Extended-Release Dipyridamole

Aspirin And Extended-release Dipyridamole

Aspirin and Extended-Release Dipyridamole is a Oral Capsule in the Human Prescription Drug category. It is labeled and distributed by American Health Packaging. The primary component is Aspirin; Dipyridamole.

• Product ID: 60687-305_809cab53-3d29-b85b-e053-2991aa0af224
• NDC: 60687-305
• Product Type: Human Prescription Drug
• Proprietary Name: Aspirin and Extended-Release Dipyridamole
• Generic Name: Aspirin And Extended-release Dipyridamole
• Dosage Form: Capsule
• Route of Administration: ORAL
• Marketing Start Date: 2017-10-20
• Marketing End Date: 2019-11-30
• Marketing Category: ANDA / ANDA
• Application Number: ANDA206392
• Labeler Name: American Health Packaging
• Substance Name: ASPIRIN; DIPYRIDAMOLE
• Active Ingredient Strength: 25 mg/1; mg/1
• Pharm Classes: Platelet Aggregation Inhibitor [EPC],Decreased Platelet Aggregation [PE],Cyclooxygenase Inhibitors [MoA],Decreased Prostaglandin Production [PE],Anti-Inflammatory Agents, Non-Steroidal [CS],Nonsteroidal Anti-inflammatory Drug [EPC],Decreased Platelet Aggregation [PE],Platelet Aggregation Inhibitor [EPC]
• NDC Exclude Flag: N

Packaging

NDC 60687-305-32

20 BLISTER PACK in 1 BOX, UNIT-DOSE (60687-305-32) > 1 CAPSULE in 1 BLISTER PACK (60687-305-33)

• Marketing Start Date: 2017-10-20
• NDC Exclude Flag: N
• Sample Package?: N

NDC SPL Data Element Entries

NDC 60687-305-32 [60687030532]

Aspirin and Extended-Release Dipyridamole CAPSULE

• Marketing Category: ANDA
• Application Number: ANDA206392
• Product Type: HUMAN PRESCRIPTION DRUG
• Billing Unit: EA
• Marketing Start Date: 2017-10-20
• Marketing End Date: 2019-11-30

NDC 60687-305-33 [60687030533]

Aspirin and Extended-Release Dipyridamole CAPSULE

• Marketing Category: ANDA
• Application Number: ANDA206392
• Product Type: HUMAN PRESCRIPTION DRUG
• Billing Unit: EA
• Marketing Start Date: 2017-10-20
• Marketing End Date: 2019-11-30

Drug Details

Active Ingredients

Ingredient	Strength
ASPIRIN	25 mg/1

OpenFDA Data

• SPL SET ID: 423dfd08-1e1b-43f7-ab83-166ec6111608
• Manufacturer:
  • American Health Packaging
• UNII:
  • R16CO5Y76E
  • 64ALC7F90C
• RxNorm Concept Unique ID - RxCUI:
  • 259081
• Pharm Class PE:
  • Decreased Prostaglandin Production [PE]
  • Decreased Platelet Aggregation [PE]
• PHarm Class EPC:
  • Nonsteroidal Anti-inflammatory Drug [EPC]
  • Platelet Aggregation Inhibitor [EPC]
• NUI Code:
  • N0000008832
  • N0000008836
  • N0000175721
  • N0000000160
  • N0000175578
  • N0000175722

Pharmacological Class

• Cyclooxygenase Inhibitors [MoA]
• Decreased Prostaglandin Production [PE]
• Nonsteroidal Anti-inflammatory Compounds [Chemical/Ingredient]
• Nonsteroidal Anti-inflammatory Drug [EPC]
• Platelet Aggregation Inhibitor [EPC]
• Decreased Platelet Aggregation [PE]
• Decreased Platelet Aggregation [PE]
• Platelet Aggregation Inhibitor [EPC]
• Anti-Inflammatory Agents
• Non-Steroidal [CS]

Medicade Reported Pricing

60687030533 ASPIRIN-DIPYRIDAM ER 25-200 MG

Pricing Unit: EA | Drug Type:

60687030532 ASPIRIN-DIPYRIDAM ER 25-200 MG

Pricing Unit: EA | Drug Type:

NDC Crossover Matching brand name "Aspirin and Extended-Release Dipyridamole" or generic name "Aspirin And Extended-release Dipyridamole"

NDC	Brand Name	Generic Name
42291-116	Aspirin and Extended-Release Dipyridamole	Aspirin and Extended-Release Dipyridamole
42571-274	ASPIRIN AND EXTENDED-RELEASE DIPYRIDAMOLE	ASPIRIN and Extended-Release DIPYRIDAMOLE
51407-271	Aspirin and Extended-Release Dipyridamole	Aspirin and Extended-Release Dipyridamole
60687-305	Aspirin and Extended-Release Dipyridamole	Aspirin and Extended-Release Dipyridamole
62175-330	Aspirin and Extended-Release Dipyridamole	Aspirin and Extended-Release Dipyridamole
62559-850	Aspirin and Extended-Release Dipyridamole	Aspirin and Extended-Release Dipyridamole
65162-596	Aspirin and Extended-Release Dipyridamole	Aspirin and Extended-Release Dipyridamole